# CareTrust REIT Inc. (CTRE) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Real Estate / Health Care REITs. Price $36.71, market value $8.7 billion.

## Valuation
- **P/E (trailing): 22.9×** (5-yr avg 29.8×, 3-yr avg 31.5×). CareTrust REIT Inc. trades at 22.9× trailing earnings, well below its own five-year average of 29.8×: cheap by its own standards. The Real Estate median in the September 2026 study was 25.2×. Forward P/E is 19.6×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.20**. A PEG of 0.20 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 160.8×**. Each dollar of revenue is priced at 160.8×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 1.9×**. The shares trade at 1.9× book value; book value is a meaningful part of the valuation.
- **Earnings yield: 4.4%**. The inverse of the P/E: 4.4% of the price is earned each year.

## Profitability
- **Return on equity: 7.9%**. 7.9% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on assets: 6.9%**. Each dollar of assets produces 6.9% of profit.

## Growth
- **EPS growth (1 yr): 96.3%** (5-yr 13.1%/yr). Earnings per share rose 96.3%.

## Financial health
- **Debt to equity: 0.22**. Debt is 0.22 times equity: a conservative balance sheet.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 4.25%** ($1.45 per share, trailing). CareTrust REIT Inc. yields 4.25%, an income-level yield.
- **Payout ratio: 81%**. 81% of earnings goes out as dividends, leaving a thin cushion.
- **Consecutive years of increases: 6**. 6 straight years of increases.
- **Dividend growth (5 yr): 6.0%/yr** (1-yr 15.5%). The dividend has grown 6.0% a year over five years.

## Analyst view
- **Analyst consensus: strong_buy** (14 analysts). 14 analysts cover CareTrust REIT Inc.; the consensus is strong_buy, with an average price target of $43.64 (+19% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 7.4%** (YTD 2.0%, 3-mo -12.3%). The shares are up 7.4% over twelve months including dividends.
- **From 52-week high: -15.8%** (6.3% above the low). Trading 16% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 46**. An RSI of 46 is neutral.
- **Beta (1 yr): 0.03** (volatility 25%). Beta of 0.03 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CTRE · Page: https://foliofundamentals.com/stocks/ctre

Not investment advice.